Request Deal Involvement

Woodline Partners and RA Capital Management led a $89m Series B round in Frontier Medicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Paul Hastings

legal advisors

Paul Hastings

or

Principals

ARROWMARK PARTNERS

bidder

ARROWMARK PARTNERS

DEERFIELD MANAGEMENT COMPANY

bidder

DEERFIELD MANAGEMENT COMPANY

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

SPHERA HEALTHCARE

bidder

SPHERA HEALTHCARE

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

FRONTIER MEDICINES

target

FRONTIER MEDICINES

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

DRIEHAUS CAPITAL

bidder

DRIEHAUS CAPITAL

DATA COLLECTIVE (DCVC)

bidder

DATA COLLECTIVE (DCVC)

DROIA VENTURES

bidder

DROIA VENTURES

MPM CAPITAL

bidder

MPM CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Woodline Partners and RA Capital Management led a $89m Series B round in Frontier Medicines.